The global Next Generation Sequencing Market is expected to reach USD 23.59 Billion by 2027, according to a new report by Emergen Research. The benefits of high-performance sequencing compared to other generations, such as the sanger-seq and microarrays, are one of the main drivers of the Next Generation Sequencing (NGS) industry. Therefore, it is expected that the increased availability of low input DNA sampling methods would speed up the use of next-generation sequence across various clinical and research applications.

The latest research report by Emergen Research, named ‘Global Next-Generation Sequencing Market. The report provides a detailed outlook on how the pandemic has affected the key segments of the Next-Generation Sequencing Market industry. The report includes an in-depth impact analysis of the COVID-19 pandemic on the overall Next-Generation Sequencing Market industry. It also offers valuable data to assist the investors in formulating strategic business investment plans and capitalize on the emerging growth prospects in the Next-Generation Sequencing Market 

Request a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/8

Competitive Terrain:

The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Next-Generation Sequencing market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.

The leading market contenders listed in the report are:

Illumina, Inc., BGI Group, Thermo Fisher Scientific, Inc., PerkinElmer Inc., Hamilton Company, Macrogen, Lucigen, Partek Incorporated, Intrexon Bioinformatics GmbH, and DNASTAR.

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/next-generation-sequencing-market

Emergen Research has segmented the global Next-Generation Sequencing market on the basis of type, application, end-use, and region:

Technology Outlook (Revenue, USD Billion; 2017-2027)

• Whole Genome Sequencing
• Whole Exome Sequencing
• Targeted Sequencing & Resequencing

Workflow Outlook (Revenue, USD Billion; 2017-2027)

• Pre-sequencing
• Sequencing
• NGS Data Analysis

Application Outlook (Revenue, USD Billion; 2017-2027)

• Clinical Investigation
• Oncology
• Reproductive Health
• HLA Typing/Immune System Monitoring
• Metagenomics, Epidemiology & Drug Development
• Agrigenomics & Forensics
• Consumer Genomics

The various regions analyzed in the report include:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Objectives of the Report:

• Analysis and estimation of the Next-Generation Sequencing Market size and share for the projected period of 2022-2030
• Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
• Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Next-Generation Sequencing Market
• Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
• Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/8